Electroporation with Cisplatin against Metastatic Pancreatic Cancer: In Vitro Study on Human Primary Cell Culture

Abstract EN

Despite the rapid progression of cancer pharmacotherapy, the high drug resistance of pancreatic ductal adenocarcinoma (PDA) makes it one of the most lethal malignancies.

Therefore, there are high expectations associated with experimental therapies, such as electrochemotherapy (ECT).

This technique involves the application of short electric pulses to induce transitional permeabilization of the cellular membrane, thus enhancing drug molecules influx.

The aim of the study was to investigate the influence of electroporation with cisplatin (CisEP) on the primary culture of human PDA cells from lung metastases—their survival and stress response.

Considering the growing importance of various research models, two established human PDA cell lines, EPP85-181P (sensitive to daunorubicin) and EPP85-181RDB (resistant to daunorubicin), were utilized as a reference control.

Cisplatin revealed higher cytotoxicity towards established cell lines.

Following CisEP application, we observed a significant decrease of cells viability in the primary culture model.

After CisEP therapy, an increased immunoreactivity with SOD-2 and Casp-3 antibodies was noticed.

In conclusion, we discovered that electroporation can enhance the cytotoxic effect of cisplatin in pancreatic cancer cells in vitro.

This effect was evident for cells from the primary culture.

The obtained results confirm the importance of primary cells models in studies on the efficacy of experimental cancer therapies.